UNC Hemophilia Treatment Center physical therapist Jennifer Newman, PT, MSPT, will moderate and speak at sessions on August 24, 2017 and August 25, 2017 at the National Hemophilia Foundation annual meeting in Chicago.
The HHT International Scientific Conference is held every other year. It is the premier conference on HHT, and over 250 basic and clinical researchers from around the world attend and present their work. The 12th HHT International Scientific Conference was held from June 8-11, 2017 in Dubrovnik.
The 9th Symposium on Hemostasis, "Advances in the Clinical and Basic Sciences of Coagulation," will be held April 12-14, 2018, in Chapel Hill, North Carolina.
UNC-Chapel Hill Drs. Nigel Key and Alisa Wolberg were featured in a recent ASH video about thrombosis research.
Dr. Nigel Key, Professor of Medicine and Pathology, Chief of the Section of Classical Hematology, and the Director of the UNC Hemophilia and Thrombosis Center, was a keynote speaker at the annual Earl W. Davie Symposium in Vancouver, BC on November 17, 2016.
Dr. Abajas received a two-year award (July 1, 2016 - June 30, 2018) to support clinical and research training in bleeding and clotting disorders.
The International Society on Thrombosis and Hemostasis will hold its Advanced Training Course in Thrombosis and Hemostasis in Atlanta, Georgia, November 1-4, 2016. UNC Hemophilia and Thrombosis Center Director Nigel Key, M.D., is chairing and speaking, and UNC physician Stephan Moll, M.D., is speaking as well.
"Endeavors" magazine, which writes about research and creative activity at UNC-Chapel Hill, published an article in its July issue about UNC-Chapel Hill's history of research and treatment for blood disorders, which began in 1947 under Dr. Kenneth Brinkhous. His seminal work set the stage for major breakthroughs in hemophilia and HIV.
Kovaltry is designed to reduce bleeding in patients with hemophilia A when infused prophylactically two or three times per week, and was approved by the European Commission on Feb. 22.
Patients can go up to two weeks between infusions.